Tessera Defense & Homeland Security

HLSQNYSE United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.970 M

$0.72 +2.19%

Close of 21 Sept 2026

Revenue

—

Not reported

Earnings

-$36.2M

Loss-making

Shares outstanding

10,146,516

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Tessera Defense & Homeland Security lists more than one class of stock. Company figures above cover all classes combined.

PHGE

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 160 →

#156Silexion TherapeuticsSLXN$3.13M
#157Calidi BiotherapeuticsCLDI$2.96M
#158CurisCRIS$2.04M
#159Tessera Defense & Homeland SecurityHLSQ$1.97M
#160Scinai ImmunotherapeuticsSCNI$847.3K

What if Tessera Defense & Homeland Security were worth as much as…

Open the what-if tool →

Gold $30.3T

$11,089,397

Per share 15,369,920× higher

Bitcoin $1.72T

$629,964.73

Per share 873,132× higher

Nvidia $5.48T

$2,007,274

Per share 2,782,085× higher

Or at a round number

$5.00M $10.0M $20.0M $50.0M

Where these numbers come from

Share counts and financials for Tessera Defense & Homeland Security are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 22 Sept 2026. Read the methodology.